Mirum Pharmaceuticals MIRM
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$2.85M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 38.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 9.99% to 10.05% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +403,449 | 6.2% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +342,383 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +333,232 | 7.2% |
| Thrivent Investment Management, Inc. | Mutual Fund | 2026/Q3 | +303,475 | 0.5% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +285,369 | 0.4% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +256,559 | 4.0% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +244,446 | 3.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +219,992 | 3.7% |
| Fisher Investments | Mutual Fund | 2026/Q3 | +113,723 | 0.3% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +104,808 | 1.9% |
| Impax Asset Management Group Plc | Mutual Fund | 2026/Q3 | +100,000 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +1,704,945 | 5.7% |
| William Blair Investment Management, LLC | Mutual Fund | 2026/Q3 | +1,108,302 | 2.2% |
| Invesco Ltd. | Mutual Fund | 2026/Q3 | +1,096,862 | 2.1% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +944,936 | 3.7% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 10 Nov 2026 | Laura Brege | Independent Director | Derivative Exercise and Sale | -14,167 | $94.74 | 15,703 |
| 3 Nov 2026 | Joanne M. Quan | Former Chief Medical Officer | Intent to Sell (Form 144) | -14,684 | $96.97 | – |
| 3 Nov 2026 | Christopher Peetz | Chief Executive Officer | Derivative Exercise and Sale | -20,000 | $90.00 | 394,137 |
| 15 Oct 2026 | Jolanda Howe | Senior VP & Global Controller | Derivative Exercise and Retained | +16,112 | $19.24 | 16,728 |
| 8 Oct 2026 | Rob Myers | Chief Medical Officer | Other Derivative Acquisition | +25,000 | – | 25,000 |
| 8 Oct 2026 | Rob Myers | Chief Medical Officer | Other Derivative Acquisition | +40,000 | $86.01 | 40,000 |
| 5 Oct 2026 | Christopher Peetz | Chief Executive Officer | Derivative Exercise and Retained | +12,197 | $19.19 | 394,137 |
| 20 Sep 2026 | Rob Myers | Chief Medical Officer | Initial Statement of Beneficial | +0 | – | 55 |
| 13 Sep 2026 | Eric Bjerkholt | Chief Financial Officer | Intent to Sell (Form 144) | -9,943 | $98.37 | – |
| 13 Sep 2026 | Eric Bjerkholt | Chief Financial Officer | Derivative Exercise and Sale | -9,943 | $98.37 | 44,745 |
| 10 Sep 2026 | Eric Bjerkholt | Chief Financial Officer | Derivative Exercise and Retained | +8,390 | – | 44,745 |
| 1 Sep 2026 | Jolanda Howe | Senior VP & Global Controller | Automatic Disposition | -658 | $100.00 | 616 |
| 31 Aug 2026 | Christopher Peetz | Chief Executive Officer | Derivative Exercise and Sale | -30,000 | $98.91 | 381,940 |
| 17 Aug 2026 | Jolanda Howe | Senior VP & Global Controller | Derivative Exercise and Sale | -40,000 | $100.00 | 1,274 |
| 10 Aug 2026 | Eric Bjerkholt | Chief Financial Officer | Automatic Disposition | -6,001 | $99.90 | 36,355 |
| 9 Aug 2026 | Christopher Peetz | Chief Executive Officer | Derivative Exercise and Sale | -20,000 | $100.14 | 381,809 |
| 2 Aug 2026 | Jolanda Howe | Senior VP & Global Controller | Automatic Disposition | -1,840 | $105.29 | 1,274 |
| 5 Jul 2026 | Eric Bjerkholt | Chief Financial Officer | Automatic Disposition | -5,000 | $124.94 | 42,181 |
| 5 Jul 2026 | Christopher Peetz | Chief Executive Officer | Derivative Exercise and Sale | -20,000 | $124.79 | 381,809 |
| 30 Jun 2026 | Jolanda Howe | Senior VP & Global Controller | Automatic Disposition | -2,721 | $120.00 | 3,114 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 6,523,716 | 10.0% | 11.8 |
| 15 Oct 2026 | 6,663,045 | 10.3% | 7.3 |
| 30 Sep 2026 | 6,985,385 | 10.8% | 7.7 |
| 15 Sep 2026 | 6,281,413 | 9.7% | 12.0 |
| 31 Aug 2026 | 6,171,979 | 9.5% | 13.2 |
| 14 Aug 2026 | 6,489,383 | 10.0% | 7.3 |
No comments yet — be the first to weigh in on MIRM.
Sign in to join the discussion.